DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Nanomedicine Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
The Global Nanomedicine Market is poised to grow at a CAGR of around 16.6% over the next decade to reach approximately $1.3 trillion by 2025.
This industry report analyzes the global markets for Nanomedicine across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.
The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Emerging applications of nanotechnology in drug delivery
3.1.2 Single & Multi Walled Carbon Nanotubes in Cancer Treatment
3.1.3 Recent Technological innovations in applications of Nanomedicine
4 Nanomedicine Market, By Product
4.1 Regenerative Medicine
4.2 In-vitro & In-vivo Diagnostics
4.3 Vaccines
4.4 Therapeutics
4.5 Drug Delivery
4.6 Biomaterials
5 Nanomedicine Market, By Application
5.1 Clinical Cardiology
5.2 Neurology
5.3 Clinical Oncology
5.4 Urology
5.5 Genetics
5.6 Orthopedics
5.7 Ophthalmology
5.8 Infectious diseases
5.9 Pneumology
5.10 Obstetrics
5.11 Immunology
5.12 Dentistry
5.13 Dermatology
5.14 Molecular Diagnostics
5.15 Anti-Infectives
5.16 Anti-Inflammatory
6 Nanomedicine Market, By Geography
7 Leading Companies
- 3M Company
- Abbott Laboratories
- Celgene Corporation
- CombiMatrix Corp
- GE Healthcare
- Johnson & Johnson
- Mallinckrodt plc
- Merck & Co. Inc.
- Nanosphere Inc.
- Pfizer Inc.
- Sigma-Tau Pharmaceuticals Inc.
- Smith & Nephew PLC
- Stryker Corp
- Teva Pharmaceutical Industries Ltd.
- UCB (Union chimique belge) S.A
For more information visit http://www.researchandmarkets.com/research/cd5j85/global
